Penfluridol is a potent first-generation diphenylbutylpiperidine antipsychotic agent primarily prescribed for the management of chronic schizophrenia and related psychotic disorders. By acting as a dopamine… Read more

































Penfluridol is a potent first-generation diphenylbutylpiperidine antipsychotic agent primarily prescribed for the management of chronic schizophrenia and related psychotic disorders. By acting as a dopamine D2 receptor antagonist, this medication modulates neurological pathways to manage symptoms. To ensure the safety and efficacy of the active pharmaceutical ingredient, laboratories utilize a comprehensive range of Penfluridol reference standards for rigorous quality control and method validation. This collection includes critical compounds such as pharmacopeial and non-pharmacopeial impurities, as well as degradation products and metabolites essential for accurate impurity profiling during stability studies. Additionally, stable isotope labelled versions of Penfluridol are available to serve as high-precision internal standards in mass spectrometry-based analytical testing, allowing for robust quantitative and qualitative verification of the drug and its related substances in complex pharmaceutical matrices.